Ruhvenile is one of India’s best R&D-based startup companies.
Ruhvenile develops indigenous products through R&D, that promote sustainable development of our society. Among our technologies, one has been recognized as having national significance as well as international recognition from Paris, France.
Ruhvenile is committed to promoting better well-being in society in a preventive manner and providing cutting-edge diagnostic kits on its own as well as in collaboration with other national and international players. The company can work and collaborate on different diseases due to its experiences, but it is currently focused on Antimicrobial resistance, Diabetes, Obesity, and Cancer and is ready to promote diagnostic kits in India.
It is involved in human health activities and basic and translational studies in collaboration with other companies and leading research institutes/universities.
With over 22 years of extensive basic & translational research experience, Dr. Rajkumar Halder has the drive to make India an innovation powerhouse.
Dr. Rajkumar Halder, CEO, and Founder of Ruhvenile Biomedical has 22+ years of extensive basic and translational research experience in Chemistry, Chemical Biology, and Drug Discovery including 10+ years abroad.
He has worked with leading research institutes and universities around the globe like the Indian Institute of Technology, Kharagpur, India; The Scripps research institute, La Jolla, CA, USA; and Max Planck Institute, Germany. He has industrial expertise with Novartis (GNF), San Diego, CA, USA.
Dr. Rajkumar Halder has worked with Nobel laureate (2021) professor Benjamin List.